Delivery Order SPE2DB24D2205-SPE2DB24FDVQD
Award Date
6/14/24
Potential Completion Date
6/17/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The $1,170.59 Firm Fixed Price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $1,095.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,274.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 25, 2023. The contract has an ultimate completion date of August 28, 2023 and is not designated as a set-aside.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,604.16 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,414.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of a pharmaceutical product, CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract has a firm fixed price of $6,213.04 and a completion date of April 25, 2024. The contract is a delivery order, which is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,022.24 firm-fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to various government agencies and healthcare programs....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML to the U.S. government. The contract, valued at $1,604.16, was awarded on May 8, 2024 with a completion date of May 9, 2024. It is a Firm Fixed Price Delivery Order contract issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA).
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $1,471.55 firm-fixed-price delivery order contract for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,828.34, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...